Moderna is suing fellow vaccine developers Pfizer and its German partner BioNTech, accusing it of infringing on patents related to mRNA technology used in their COVID-19 vaccine, the company announced ...
Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE, more than ​five years after both ...
Moderna MRNA has filed lawsuits against rivals Pfizer PFE and BioNTech BNTX, alleging that their COVID-19 vaccine, Comirnaty infringes on patents related to its mRNA technology platform. The ...
By updating the genetic code inside mRNA vaccines every year, scientists can keep population-level immunity aligned with ...
[NEW YORK] Pfizer is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech, a remnant from one of the ...
Pfizer (PFE) may be the most recognized COVID-19 vaccine brand, but that's due in part to its collaboration with BioNTech (BNTX). It's why the companies recently announced they're expanding their ...
(Reuters) - CureVac NV said on Friday it had filed an expanded patent infringement claim against Pfizer Inc and BioNTech over the use of mRNA technology and that a U.S. court had granted its request ...
When most of us think of mRNA technology, we probably think of Moderna(NASDAQ: MRNA). The biotech company put messenger RNA on the map when it brought the first coronavirus vaccine candidate into ...
Pfizer Inc. is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech SE, a remnant from one of the ...
The US drugmaker is offering about 4.55 million American depositary receipts via an overnight block trade marketed between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results